PRESS RELEASE published on 04/24/2025 at 17:45, 7 months 10 days ago Invibes : 2025/2026 financial agenda Invibes Advertising announces its financial agenda for 2025/2026, including key revenue and results dates. Utilizing proprietary technology for efficient and value-driven advertising solutions Invibes Advertising Financial Agenda Proprietary Technology Advertising Solutions Revenue Dates
BRIEF published on 03/26/2025 at 17:50, 8 months 9 days ago Invibes Advertising: 2024 Review EBITDA Artificial Intelligence Digital Advertising Investments Turnover
PRESS RELEASE published on 03/26/2025 at 17:45, 8 months 9 days ago Invibes Advertising : Annual results 2024. Invibes Advertising reports 6% decrease in total sales for 2024, driven by investment in generative AI and International expansion. EBITDA growth in scale-up countries Generative AI Invibes Advertising International Expansion EBITDA Growth Total Sales Decrease
BRIEF published on 03/24/2025 at 17:50, 8 months 11 days ago Strategic appointments at Invibes Advertising to drive growth Appointments International Growth Digital Advertising GenAI Hyper-personalization
PRESS RELEASE published on 03/24/2025 at 17:45, 8 months 11 days ago Invibes Advertising announces two strategic appointments to accelerate growth. Invibes Advertising announces strategic appointments of Stève Saleyron and Stéphane Allard to accelerate growth. Commitment to hyper-personalised advertising with Generative AI for global markets Generative AI Invibes Advertising Global Growth Strategic Appointments Hyper-personalised Advertising
BRIEF published on 01/22/2025 at 17:50, 10 months 13 days ago Invibes Advertising revenue for the fourth quarter of 2024 International Growth Digital Advertising Turnover France Stratégies 2025
PRESS RELEASE published on 01/22/2025 at 17:45, 10 months 13 days ago Invibes Advertising : 2024 Fourth Quarter Sales. Invibes Advertising reports €8.7m Q4 2024 sales, down 16% from 2023. Strategic priorities for 2025 include AI integration, vertical solutions, targeted recruitment in sales teams AI Integration Strategic Priorities Invibes Advertising Sales Figures Q4 2024
BRIEF published on 01/07/2025 at 17:45, 10 months 28 days ago Half-yearly report and termination of the liquidity contract for Invibes Advertising Liquidity Contract TP ICAP Half-yearly Report Invibes Advertising VP VENTURE NV
PRESS RELEASE published on 01/07/2025 at 17:40, 10 months 28 days ago Invibes Advertising : Half-yearly report and termination of the liquidity contract. Invibes Advertising terminates liquidity contract with VP VENTURE NV. Half-yearly report reveals shares and cash in liquidity account Liquidity Contract Shares Half-yearly Report Invibes Advertising Cash
BRIEF published on 10/23/2024 at 17:50, 1 year 1 month ago Invibes Advertising Reports 4% Growth in Q3 2024 Sales Growth Strategy AI Integration International Expansion Q3 2024 Sales Vertical Solutions
Published on 12/05/2025 at 02:35, 4 hours 15 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 50 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 45 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 50 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 20 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 59 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 25 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 35 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 39 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 50 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 5 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 6 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 49 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
